TABLE 4.
Performance of MRE for in patients with NAFLD.
| Authors | Year | Size | Mean BMI (kg/m2) | Failure rate (%) | F3-F4 (%) | Cut-offs value (kPa) | AUROC | Se | Sp |
|---|---|---|---|---|---|---|---|---|---|
| Loomba et al | 2014 | 117 | 32.4 | 0 | 19 | 3.6 | 0.92 | 82 | 90 |
| Cui et al | 2015 | 102 | 31.7 | 0 | 19 | 3.6 | 0.96 | 92 | 90 |
| Loomba et al | 2016 | 100 | 32.1 | 0 | 15 | 3.8 | 0.92 | 80 | 95 |
| Imajo et al | 2016 | 142 | 28.1 | 0 | 32 | 4.8 | 0.89 | 75 | 87 |
| Park et al | 2017 | 104 | 30.4 | 0 | 17 | 3.0 | 0.87 | 78 | 80 |
| Chen et al | 2017 | 111 | 40.3 | 4.5 | 20 | 3.6 | 0.92 | 84 | 83 |
AUROC, area under ROC, curve; CC, correctly classified: true positive and true negative; NAFLD, Non-alcoholic fatty liver disease; NA, not available; Se = sensitivity; Sp = specificity.